Company Filing History:
Years Active: 2024
Title: Buccioni Michela: Innovator in Adenosine Receptor Activity
Introduction
Buccioni Michela is a notable inventor based in Camerino, Italy. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target adenosine receptors. His work has the potential to address various pathological conditions affecting the nervous system.
Latest Patents
Michela holds a patent for "Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylates." This patent includes adenosine receptor active compounds, such as 1,2,3,6,8-pentasubstituted indolizines. The methods described in the patent can be utilized to inhibit adenosine receptor activity, which may be beneficial in treating conditions like allergies, inflammation, glaucoma, brain ischemia, renal fibrosis, cancer, rheumatoid arthritis, psoriasis, fatty liver diseases, stroke, and pain.
Career Highlights
Michela is affiliated with King Fahd University of Petroleum and Minerals, where he continues to advance his research in pharmacology. His innovative approach to drug development has garnered attention in the scientific community.
Collaborations
Michela has collaborated with esteemed colleagues, including Katharigatta N Venugopala and Gabriella Marucci. These partnerships have enhanced the scope and impact of his research.
Conclusion
Buccioni Michela is a prominent figure in the field of pharmacology, with a focus on adenosine receptor activity. His patent and ongoing research hold promise for the treatment of various neurological conditions.